The process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing, followed by trials in humans to determine the efficacy of the drug.
Faculty Researching Drug Development
James Bibb
Translational Neurosciences
Roberta Brinton
Pharmacology
Thomas Davis
Pharmacology
Torsten Falk
Neurology
Amelia Gallitano
Basic Medical Sciences
Tally Largent-Milnes
Pharmacology
Robin Polt
Chemistry & Biochemistry
Frank Porreca
Pharmacology
John Regan
Pharmacology and Toxicology
Linda Restifo
Neurology
Kathleen Rodgers
Pharmacology
Patrick Ronaldson
Pharmacology
Scott Sherman
Neurology
John Streicher
Pharmacology
Todd Vanderah
Pharmacology
Xinglong Wang
Pharmacology and Toxicology